Join us for the SDG Leadership Forum for Goal 3 on Wednesday 28th March 2018. As part of our ongoing series of online dialogues, the SDG Leadership Forum for Goal 3 (Ensure Healthy Lives and Promote Wellbeing) is a chance for us to make a significant impact together and advance progress on the Global Goals. In this live, online, text-based discussion, hosted by Johnson & Johnson and GlobeScan, we will focus on capacity building and empowering women in the healthcare … “Johnson & Johnson and GlobeScan to Host SDG Leadership Forum for Goal 3: Good Health and Well-Being”
A report on Pharmaceutical sector intelligence, drawn from GlobeScan Radar’s 2014 study of global public attitudes towards business in society.
Petra Laux is the Head of Global Public and Government Affairs at Novartis, a position she assumed in 2006. In this role, she creates strategy and overseas implementation of all public and government affairs activities for the Novartis Group of companies, including the divisions Pharmaceuticals, Alcon, and Sandoz. GlobeScan co-CEO Christophe Guibeleguiet recently interviewed Petra to gain insight on the value Novartis puts on stakeholder intelligence to help build recognized leadership in an uncertain world. You have been with Novartis … “Recognizing Leaders: Petra Laux, Novartis”
In uncertain and volatile times, global organizations need greater insight on how to better manage risks and capitalize on opportunities, build trust with their stakeholders and society, and exert a greater influence in shaping their external context. Faced with these challenges, what can those charged with managing companies and their reputation do to stay ahead of the game? To help equip corporate leaders to take on these challenges, we are publishing 14 sector intelligence reports (covering Automotive, Banking, Beer, Chemical, Clothing, Electricity, Food, IT/Tech, Media and Entertainment, Mining, Oil and Petroleum, Pharmaceutical, Supermarkets, and … “Understanding Views on Business – GlobeScan Radar Infographic and Sector Intelligence Reports”
A report on Pharmaceutical sector intelligence, drawn from GlobeScan Radar’s 2013 study of global public attitudes towards business in society.
This GlobeScan Stakeholder Intelligence eBrief explores the issues and reputation affecting the pharmaceutical industry, drawing on a decades worth of public opinion research.